Singapore Paincare Holdings Limited (SGX:FRQ)
0.1590
+0.0010 (0.63%)
At close: Nov 25, 2025
SGXC:FRQ Balance Sheet
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2017 - 2020 |
| Cash & Equivalents | 5.2 | 6.86 | 9.64 | 15.17 | 15.84 | Upgrade
|
| Short-Term Investments | 0.41 | 0.36 | 0.32 | 0.6 | 0.1 | Upgrade
|
| Cash & Short-Term Investments | 5.61 | 7.22 | 9.95 | 15.77 | 15.94 | Upgrade
|
| Cash Growth | -22.26% | -27.49% | -36.88% | -1.08% | 220.60% | Upgrade
|
| Accounts Receivable | 2.53 | 2.63 | 2.21 | 1.83 | 1.21 | Upgrade
|
| Other Receivables | 0.09 | 0.09 | 0.13 | 0.29 | 0.18 | Upgrade
|
| Receivables | 2.63 | 2.72 | 2.34 | 2.11 | 1.4 | Upgrade
|
| Inventory | 1.95 | 1.56 | 1.28 | 1.02 | 0.77 | Upgrade
|
| Prepaid Expenses | 0.9 | 0.28 | 0.47 | 0.13 | 0.1 | Upgrade
|
| Other Current Assets | - | 1 | - | - | 0.06 | Upgrade
|
| Total Current Assets | 11.08 | 12.78 | 14.04 | 19.03 | 18.27 | Upgrade
|
| Property, Plant & Equipment | 7.28 | 8.65 | 7.76 | 5.52 | 2.19 | Upgrade
|
| Long-Term Investments | 4.44 | 5.57 | 4.44 | 1.24 | 2.24 | Upgrade
|
| Goodwill | 10.89 | 13.55 | 13.42 | 10.3 | 6.47 | Upgrade
|
| Other Intangible Assets | 1.02 | 0.03 | 0.07 | 0.11 | 0.15 | Upgrade
|
| Long-Term Accounts Receivable | 0.02 | 0.02 | - | 0.02 | - | Upgrade
|
| Other Long-Term Assets | - | - | 0.47 | 2.51 | 1.88 | Upgrade
|
| Total Assets | 34.73 | 40.6 | 40.21 | 38.73 | 31.2 | Upgrade
|
| Accounts Payable | 0.34 | 0.22 | 0.17 | 0.3 | 0.08 | Upgrade
|
| Accrued Expenses | 1.72 | 1.93 | 1.58 | 1.56 | 0.59 | Upgrade
|
| Current Portion of Long-Term Debt | 2.2 | 3.13 | 5.37 | 0.73 | 0.81 | Upgrade
|
| Current Portion of Leases | 2.14 | 1.93 | 1.64 | 1.2 | 0.66 | Upgrade
|
| Current Income Taxes Payable | 0.59 | 0.89 | 1.29 | 1.19 | 0.79 | Upgrade
|
| Current Unearned Revenue | 0.13 | 0.08 | 0.13 | 0.09 | 0.03 | Upgrade
|
| Other Current Liabilities | 0.88 | 1.66 | 2.34 | 1.12 | 0.34 | Upgrade
|
| Total Current Liabilities | 7.99 | 9.82 | 12.52 | 6.19 | 3.31 | Upgrade
|
| Long-Term Debt | 1.8 | 0.6 | 0.77 | 2.22 | 2.97 | Upgrade
|
| Long-Term Leases | 4.94 | 5.81 | 4.58 | 3.79 | 1.37 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.8 | 0.72 | 0.7 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.59 | 0.63 | 0.28 | 0.05 | 0.03 | Upgrade
|
| Total Liabilities | 16.13 | 17.57 | 18.86 | 12.26 | 7.68 | Upgrade
|
| Common Stock | 25.68 | 25.68 | 25.68 | 25.68 | 25.68 | Upgrade
|
| Retained Earnings | -0.11 | 3.92 | 2.56 | 5.8 | 3.25 | Upgrade
|
| Treasury Stock | -1.73 | -1.73 | -1.73 | - | - | Upgrade
|
| Comprehensive Income & Other | -5.38 | -5.38 | -5.38 | -5.38 | -5.38 | Upgrade
|
| Total Common Equity | 18.47 | 22.5 | 21.13 | 26.11 | 23.56 | Upgrade
|
| Minority Interest | 0.14 | 0.53 | 0.21 | 0.36 | -0.04 | Upgrade
|
| Shareholders' Equity | 18.6 | 23.03 | 21.35 | 26.47 | 23.51 | Upgrade
|
| Total Liabilities & Equity | 34.73 | 40.6 | 40.21 | 38.73 | 31.2 | Upgrade
|
| Total Debt | 11.08 | 11.46 | 12.37 | 7.94 | 5.82 | Upgrade
|
| Net Cash (Debt) | -5.47 | -4.24 | -2.41 | 7.83 | 10.12 | Upgrade
|
| Net Cash Growth | - | - | - | -22.66% | 2828.46% | Upgrade
|
| Net Cash Per Share | -0.03 | -0.02 | -0.01 | 0.04 | 0.06 | Upgrade
|
| Filing Date Shares Outstanding | 171.01 | 171.01 | 171.01 | 179.62 | 179.62 | Upgrade
|
| Total Common Shares Outstanding | 171.01 | 171.01 | 171.01 | 179.62 | 179.62 | Upgrade
|
| Working Capital | 3.09 | 2.95 | 1.52 | 12.84 | 14.96 | Upgrade
|
| Book Value Per Share | 0.11 | 0.13 | 0.12 | 0.15 | 0.13 | Upgrade
|
| Tangible Book Value | 6.56 | 8.92 | 7.64 | 15.7 | 16.93 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | 0.05 | 0.04 | 0.09 | 0.09 | Upgrade
|
| Machinery | - | 1.15 | 1.08 | 0.45 | 0.28 | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.